(NASDAQ:FTRE), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Fortrea Holdings, Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 25-cv-04630, is […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. – DYN GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN). Such investors are advised to contact Danielle

Conflict Resolution Expert Revolutionizes 'Conflict Intelligence' – Groundbreaking Seven Levels Framework Helps Companies Transform Workplace Disputes Into Growth Opportunities Revolutionary new approach addresses complete human experience in conflict, creating sustainable solutions that strengthen teams and drive innovation Toronto, ON, Aug. 01, 2025 (GLOBE NEWSWIRE) — NAMASTE International LTD today announced the official launch of the

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. – PETS GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of WPP plc – WPP GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of WPP plc (“WPP” or the “Company”) (NYSE: WPP). Such investors are advised to contact Danielle Peyton at

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX). Such investors are advised to contact Danielle

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines – TEM GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or the “Company”)(NASDAQ:

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reddit, Inc. of Class Action Lawsuit and Upcoming Deadlines – RDDT GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Reddit, Inc. (“Reddit” or the “Company”) (NYSE:

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines – HIMS GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health,

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or the